ARTICLE | Clinical News
Entinostat: Phase II data
April 11, 2011 7:00 AM UTC
A single-arm, U.S. Phase II trial in 32 evaluable patients with recurrent, advanced NSCLC showed that oral entinostat plus 5-azacitidine produced 1 complete response, 1 partial response and 9 cases of...